Prevention of ERCP-induced pancreatitis: success at last.
Pasricha
P
P
D002760:Cholangiopancreatography, Endoscopic Retrograde / Q000009:adverse effects*; D004311:Double-Blind Method; D016670:Gabexate / Q000627:therapeutic use*; D006801:Humans; D010195:Pancreatitis / Q000209:etiology* / Q000517:prevention & control*; D015842:Serine Proteinase Inhibitors / Q000627:therapeutic use*
D015842:Serine Proteinase Inhibitors; D016670:Gabexate